Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world, and the global leader in acute hemodynamic monitoring.  Headquartered in Irvine, Calif., Edwards focuses on four main cardiovascular disease states:  heart valve disease, coronary artery disease, peripheral vascular disease and congestive heart failure.  The company's global brands, which are sold in approximately
100 countries, include Carpentier-Edwards, Cosgrove-Edwards, Swan-Ganz, Lifepath AAA and Fogarty.